Search - tctmd.com

Displaying 1 - 20 of 24

Sort: Relevancy | Date

News Conference News TCT 2025

LIFE-BTK: 3-Year Data Keep Dissolving Scaffold’s Durability Hopes Alive in CLTI

L.A. McKeown

October 27, 2025

News Conference News TCT 2024

SIRONA: Sirolimus and Paclitaxel DCBs Offer Similar Patency, Function in PAD

L.A. McKeown

October 29, 2024

News Conference News TCT 2023

LIFE-BTK: Bioresorbable Scaffold Holds Promise for Infrapopliteal CLTI

L.A. McKeown

October 25, 2023

News Conference News TCT 2023

Paclitaxel Safety Questions in PAD: Will ‘Capstone’ Data Close the Door?

L.A. McKeown

October 24, 2023

Direct Temsirolimus Delivery Shows Promise in BTK: Phase II Study

News Conference News TCT 2020

Direct Temsirolimus Delivery Promising in BTK: TANGO Phase II Study

Caitlin E. Cox

October 18, 2020

News Conference News TCT 2020

IN.PACT BTK Provides Renewed Hope for Attacking CLI With DCBs

L.A. McKeown

October 18, 2020

Presentation TCT 2020

IN.PACT BTK: A Randomzied Trial of Drug-Coated Balloon Angioplasty in the Infrapopliteal Arteries

Presenter: Antonio Micari

October 18, 2020

News Conference News TCT 2019

LEVANT: Patient-Level Data Show No Increase in 5-Year Death for Paclitaxel DCBs in PAD

L.A. McKeown

September 28, 2019

News Conference News TCT 2018

Eluvia Gains FDA Approval Just Days After IMPERIAL Results Released

Todd Neale

September 24, 2018

News Conference News TCT 2018

IMPERIAL: Eluvia Tops Zilver PTX in Battle of DES in Femoropopliteal Disease

Todd Neale

September 22, 2018

News Conference News TCT 2016

ILLUMENATE: Low-Dose DCB Bests Angioplasty Alone in Complex Patients With SFA/Popliteal Lesions

L.A. McKeown

November 07, 2016

Presentation TCT 2014

TCT 532: Economic Outcomes of Endovascular Femoropopliteal Intervention Using Drug-Coated Balloons vs Standard PTA: 1-Year Results from the IN.PACT SFA II Trial

Presenter: Peter A. Schneider, Gunnar Tepe, Michael H. Wholey, Adam Salisbury, MD

September 15, 2014

Presentation TCT 2014

Managing Acute Limb Ischemia: Which Patients Get Endovascular and When Is Bypass Preferred?

Presenter: Roger M. Greenhalgh, Michael R. Jaff, David P. Slovut, Mark H. Wholey

September 14, 2014

Presentation TCT 2014

Endovascular Approaches to Common Femoral Artery Obstructive Disease: Finally Ready for Primetime?

Presenter: Robert M. Bersin, Dierk Scheinert, Roger Gammon, Thomas Zeller

September 13, 2014

Presentation TCT 2013

Endovascular Intervention in Patients with Critical Limb Ischemia in Taiwan: Patient Outcomes in 333 Consecutive Limb Procedures with a 6-year Follow-up

Presenter: Hsuan Li Huang

January 31, 2013

News Conference News TCT 2012

ETAP Trial: Nitinol Stent Bests Angioplasty for Popliteal Artery Disease

November 18, 2012

Presentation TCT 2012

Debate I. Is Endovascular Intervention the First-line Therapy for CLI? Con!

Presenter: Jacques Busquet

October 23, 2012

Presentation TCT 2012

Debate I. Is Endovascular Intervention the First-line Therapy for CLI? Pro!

Presenter: Tony Das

October 23, 2012

Presentation TCT 2012

A Multidisciplinary Approach to CLI Is Essential: Wound Care, Risk Factor Modification, and Endovascular Therapy

Presenter: James Zidar

October 23, 2012

Presentation TCT 2012

Endovascular therapy is a must and first line treatment in patients with critical limb ischemia

Presenter: Zaza Kavteladze

May 28, 2012

Advertisement

LIFE-BTK: 3-Year Data Keep Dissolving Scaffold’s Durability Hopes Alive in CLTI

SIRONA: Sirolimus and Paclitaxel DCBs Offer Similar Patency, Function in PAD

LIFE-BTK: Bioresorbable Scaffold Holds Promise for Infrapopliteal CLTI

Paclitaxel Safety Questions in PAD: Will ‘Capstone’ Data Close the Door?

Direct Temsirolimus Delivery Promising in BTK: TANGO Phase II Study

IN.PACT BTK Provides Renewed Hope for Attacking CLI With DCBs

IN.PACT BTK: A Randomzied Trial of Drug-Coated Balloon Angioplasty in the Infrapopliteal Arteries

LEVANT: Patient-Level Data Show No Increase in 5-Year Death for Paclitaxel DCBs in PAD

Eluvia Gains FDA Approval Just Days After IMPERIAL Results Released

IMPERIAL: Eluvia Tops Zilver PTX in Battle of DES in Femoropopliteal Disease

ILLUMENATE: Low-Dose DCB Bests Angioplasty Alone in Complex Patients With SFA/Popliteal Lesions

TCT 532: Economic Outcomes of Endovascular Femoropopliteal Intervention Using Drug-Coated Balloons vs Standard PTA: 1-Year Results from the IN.PACT SFA II Trial

Managing Acute Limb Ischemia: Which Patients Get Endovascular and When Is Bypass Preferred?

Endovascular Approaches to Common Femoral Artery Obstructive Disease: Finally Ready for Primetime?

Endovascular Intervention in Patients with Critical Limb Ischemia in Taiwan: Patient Outcomes in 333 Consecutive Limb Procedures with a 6-year Follow-up

ETAP Trial: Nitinol Stent Bests Angioplasty for Popliteal Artery Disease

Debate I. Is Endovascular Intervention the First-line Therapy for CLI? Con!

Debate I. Is Endovascular Intervention the First-line Therapy for CLI? Pro!

A Multidisciplinary Approach to CLI Is Essential: Wound Care, Risk Factor Modification, and Endovascular Therapy

Endovascular therapy is a must and first line treatment in patients with critical limb ischemia

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content